entrezID,gene_symbol,biotype,bioproject,res_design,host_type,stimulator,concentration,H.P.S,baseMean,log2FoldChange,lfcSE,stat,pvalue,padj,cell_type
100505483,PRKAG2-AS1,lncRNA,PRJNA474093,IFN-beta stimulation vs. mock stimulation,immortalized human hepatocytes PH5CH8,IFN-beta,N.A.,12,37.4109390492678,-0.0363677958208302,0.323474777862537,-0.112428536348775,0.910483630026388,0.994998021163286,NA
100505483,PRKAG2-AS1,lncRNA,PRJNA565586,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,100U/ml,24,8.69944551566995,-0.669685154961656,0.675505553168825,-0.991383641215286,0.321498285099065,0.892327231915733,patient-derived GBM cell lines (PDGCLs)
100505483,PRKAG2-AS1,lncRNA,PRJNA667475,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,250U/ml,8,5.84071501850452,-0.431375696354029,0.883329820702763,-0.488351786890692,0.625300685780581,0.933906632050025,A549
100505483,PRKAG2-AS1,lncRNA,PRJNA739760,INF-alpha2 stimulation (with DMSO) vs. mock stimulation (with DMSO),NA,IFN-alpha,1000U/ml,16,2.78924532321043,-1.11779347402973,1.25792764532239,-0.888599179918052,0.374218531975818,0.986418245486816,A549
100505483,PRKAG2-AS1,lncRNA,PRJNA768480,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,N.A.,N.A.,4.22436324935724,-0.848570496979719,1.50138602455041,-0.565191418531968,0.571943572950741,0.881232646608265,A549
100505483,PRKAG2-AS1,lncRNA,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,18.9403822336269,-0.0373410427865291,0.609894290877954,-0.0612254342187332,0.951179674148417,1,sigmoid colon organoid
100505483,PRKAG2-AS1,lncRNA,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,18.9403822336269,-0.97746262580963,0.631925920486372,-1.54679938600605,0.121911628330566,0.722441445914562,sigmoid colon organoid
